Ciforadenant Uses, Dosage, Side Effects and more
Ciforadenant is under investigation in clinical trial NCT02253745 (Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)).
| Trade Name | Ciforadenant |
| Generic | Ciforadenant |
| Ciforadenant Other Names | Ciforadenant |
| Type | |
| Formula | C20H21N7O3 |
| Weight | Average: 407.434 Monoisotopic: 407.170587564 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
